Increased co-expression of PD1 and TIM3 is associated with poor prognosis and immune microenvironment heterogeneity in gallbladder cancer.
Increased co-expression of PD1 and TIM3 is associated with poor prognosis and immune microenvironment heterogeneity in gallbladder cancer.
复制标题
DOI:
10.1186/s12967-023-04589-3
复制
发表时间:
2023-10-12
影响因子:
7.4
通讯作者:
Li, Wenbin
中科院分区:
文献类型:
--
作者:
He, Xing;Peng, Yaorong;He, Gui;Ye, Huilin;Liu, Liqiang;Zhou, Qixian;Shi, Juanyi;Fu, Sha;Wang, Jie;Zhou, Zhenyu;Li, Wenbin
关键词:
The effectiveness of immune checkpoint inhibitors in treating gallbladder cancer (GBC) remains unsatisfactory. Recently, several new immune checkpoints have been identified. However, investigations exploring these immune checkpoints in GBC are limited. In this study, we aim to investigate the expression patterns and clinical implications of various immune checkpoints, and further characterize the spatial and quantitative heterogeneity of immune components in GBC. We employed single and multiplex immunohistochemistry to evaluate the expression of five immune checkpoint markers and four immune cell markers in the primary tumor core, hepatic invasion margin, and liver metastasis. Subsequently, we analyzed their interrelationships and their prognostic significance. We observed a robust positive correlation between PD1/TIM3 expression in GBC (R = 0.614, P < 0.001). The co-expression of PD1/TIM3 exhibited a synergistic effect in predicting poor prognosis among postoperative GBC patients. Further analysis revealed that the prognostic significance of PD1/TIM3 was prominent in the subgroup with high infiltration of CD8 + T cells (P < 0.001). Multiplex immunohistochemistry reveals that PD1 + TIM3 + FOXP3 + cells constitute a significant proportion of FOXP3 + TILs in GBC tissue. Moreover, the co-high expression of PD1 and TIM3 is positively correlated with the accumulation of CD8 + TILs at the hepatic invasion margin. Lastly, our findings indicated reduced expression levels of immune checkpoints and diminished immune cell infiltration in liver metastases compared to primary tumors. Increased co-expression of PD1/TIM3 is associated with poor prognosis in GBC patients and is related to the heterogeneity of immune microenvironment between GBC primary tumor and its hepatic invasion margin or liver metastases, which may be a potential target for future immunotherapy of GBC. The online version contains supplementary material available at 10.1186/s12967-023-04589-3.
登录
查看更多内容
影响因子:
120.1
作者:
Kim, Tae Kon;Vandsemb, Esten N.;Chen, Lieping
通讯作者:
Chen, Lieping
影响因子:
4.6
作者:
Bankhead P;Loughrey MB;Fernández JA;Dombrowski Y;McArt DG;Dunne PD;McQuaid S;Gray RT;Murray LJ;Coleman HG;James JA;Salto-Tellez M;Hamilton PW
通讯作者:
Hamilton PW
DOI:
10.1158/1078-0432.ccr-15-3071
发表时间:
2017-02-01
期刊:
Clinical cancer research : an official journal of the American Association for Cancer Research
影响因子:
--
作者:
Cheng H;Janakiram M;Borczuk A;Lin J;Qiu W;Liu H;Chinai JM;Halmos B;Perez-Soler R;Zang X
通讯作者:
Zang X
DOI:
10.1038/s41572-022-00403-4
发表时间:
2022-10-27
期刊:
Nature reviews. Disease primers
影响因子:
--
作者:
通讯作者:
--
影响因子:
11.2
作者:
Halama, Niels;Michel, Sara;Jaeger, Dirk
通讯作者:
Jaeger, Dirk